Combination treatment shows large improvement in survival for people with relapsed myeloma

At the American Society of Hematology Conference in Orlando, new results from the MajesTEC-3 study show that combining teclistamab with daratumumab could help people with myeloma whose cancer has come back or hasn’t responded to previous…

Continue Reading

News Source: medicalxpress.com